✦ LIBER ✦

P256 Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission

✍ Scribed by A. Molazahi; C. Steenholdt; M. Ainsworth; J. Brynskov; O. Thomsen; J. Seidelin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome after discontinuation of inflixi

✍ Steenholdt, Casper; Molazahi, Akbar; Ainsworth, Mark Andrew; Brynskov, Jørn; Tho 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 258 KB

1124 Long Term Prognosis After Discontin

✍ Casper Steenholdt; Akbar Molazahi; Mark A. Ainsworth; Jorn Brynskov; Ole Thomsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 163 KB

P108 INFLIXIMAB DISCONTINUATION IN PATIE

✍ F. Bermejo; A. López-San Román; A. Algaba; M. Van Domselaar; J.A. Carneros; E. G 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 121 KB

P.02.11 WITHDRAWAL OF INFLIXIMAB (IFX) A

✍ Luppino, I.; Spagnuolo, R.; Marasco, R.; Cosco, C.; Ruggiero, G.; Cosco, V.; Dol 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 92 KB

P275 Evaluation of the discontinuation o

✍ Z. Zelinkova; C. Van der Ent; K. Bruin; O. Van Baalen; H. Vermeulen; H. Smalbraa 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 53 KB

Su1394 Prediction of Sustained Remission

✍ Papamichail, Konstantinos; Casteele, Niels Vande; Hauenstein, Scott; Princen, Fr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB